JP2014522694A - 複数の電源を備えた通信システム - Google Patents
複数の電源を備えた通信システム Download PDFInfo
- Publication number
- JP2014522694A JP2014522694A JP2014520261A JP2014520261A JP2014522694A JP 2014522694 A JP2014522694 A JP 2014522694A JP 2014520261 A JP2014520261 A JP 2014520261A JP 2014520261 A JP2014520261 A JP 2014520261A JP 2014522694 A JP2014522694 A JP 2014522694A
- Authority
- JP
- Japan
- Prior art keywords
- power
- support structure
- conductive
- receiver
- storage unit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004891 communication Methods 0.000 title claims description 71
- 239000000463 material Substances 0.000 claims abstract description 241
- 239000012530 fluid Substances 0.000 claims abstract description 54
- 238000003860 storage Methods 0.000 claims description 36
- 239000004020 conductor Substances 0.000 claims description 35
- 230000008859 change Effects 0.000 claims description 15
- 239000004065 semiconductor Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 description 26
- 239000002775 capsule Substances 0.000 description 24
- 150000002500 ions Chemical class 0.000 description 21
- 239000000825 pharmaceutical preparation Substances 0.000 description 20
- 229940127557 pharmaceutical product Drugs 0.000 description 20
- 239000003814 drug Substances 0.000 description 18
- 230000006870 function Effects 0.000 description 18
- 238000010586 diagram Methods 0.000 description 16
- 229910052751 metal Inorganic materials 0.000 description 16
- 239000002184 metal Substances 0.000 description 16
- 150000002739 metals Chemical class 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 230000004913 activation Effects 0.000 description 11
- 238000000576 coating method Methods 0.000 description 11
- 210000001124 body fluid Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 210000002784 stomach Anatomy 0.000 description 8
- 239000003826 tablet Substances 0.000 description 8
- 239000010839 body fluid Substances 0.000 description 7
- 239000007772 electrode material Substances 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 229910052755 nonmetal Inorganic materials 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 230000001427 coherent effect Effects 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 238000003487 electrochemical reaction Methods 0.000 description 4
- 239000003792 electrolyte Substances 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 210000004051 gastric juice Anatomy 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000002843 nonmetals Chemical class 0.000 description 4
- 239000011253 protective coating Substances 0.000 description 4
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 3
- 239000012790 adhesive layer Substances 0.000 description 3
- 239000003990 capacitor Substances 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 3
- 238000012937 correction Methods 0.000 description 3
- 238000000151 deposition Methods 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007897 gelcap Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012811 non-conductive material Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SBUXRMKDJWEXRL-ZWKOTPCHSA-N trans-body Chemical compound O=C([C@@H]1N(C2=O)[C@H](C3=C(C4=CC=CC=C4N3)C1)CC)N2C1=CC=C(F)C=C1 SBUXRMKDJWEXRL-ZWKOTPCHSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000002019 doping agent Substances 0.000 description 2
- 238000004070 electrodeposition Methods 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 230000003382 ingestive effect Effects 0.000 description 2
- 230000002687 intercalation Effects 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 229940126601 medicinal product Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000005240 physical vapour deposition Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000011241 protective layer Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000006190 sub-lingual tablet Substances 0.000 description 2
- 229940098466 sublingual tablet Drugs 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 238000013268 sustained release Methods 0.000 description 2
- 239000012730 sustained-release form Substances 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000700126 Ctenodactylus gundi Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 239000010405 anode material Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011247 coating layer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 210000001731 descending colon Anatomy 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000006181 electrochemical material Substances 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- -1 for example Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000003973 paint Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000010363 phase shift Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/07—Endoradiosondes
- A61B5/073—Intestinal transmitters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14539—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/007—Marking tablets or the like
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01Q—ANTENNAS, i.e. RADIO AERIALS
- H01Q1/00—Details of, or arrangements associated with, antennas
- H01Q1/27—Adaptation for use in or on movable bodies
- H01Q1/273—Adaptation for carrying or wearing by persons or animals
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B1/00—Details of transmission systems, not covered by a single one of groups H04B3/00 - H04B13/00; Details of transmission systems not characterised by the medium used for transmission
- H04B1/02—Transmitters
- H04B1/03—Constructional details, e.g. casings, housings
- H04B1/034—Portable transmitters
- H04B1/0343—Portable transmitters to be carried on the body
-
- H—ELECTRICITY
- H04—ELECTRIC COMMUNICATION TECHNIQUE
- H04B—TRANSMISSION
- H04B13/00—Transmission systems characterised by the medium used for transmission, not provided for in groups H04B3/00 - H04B11/00
- H04B13/005—Transmission systems in which the medium consists of the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01M—PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY
- H01M6/00—Primary cells; Manufacture thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Signal Processing (AREA)
- Optics & Photonics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Near-Field Transmission Systems (AREA)
- Electric Double-Layer Capacitors Or The Like (AREA)
- Arrangements For Transmission Of Measured Signals (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Endoscopes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/180,498 | 2011-07-11 | ||
| US13/180,498 US20120004520A1 (en) | 2005-04-28 | 2011-07-11 | Communication System with Multiple Sources of Power |
| PCT/US2012/046113 WO2013009777A2 (en) | 2011-07-11 | 2012-07-10 | Communication system with multiple sources of power |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2014522694A true JP2014522694A (ja) | 2014-09-08 |
Family
ID=47506865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014520261A Pending JP2014522694A (ja) | 2011-07-11 | 2012-07-10 | 複数の電源を備えた通信システム |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20120004520A1 (enExample) |
| EP (1) | EP2731495A4 (enExample) |
| JP (1) | JP2014522694A (enExample) |
| KR (1) | KR20140126282A (enExample) |
| CN (1) | CN103781412A (enExample) |
| AU (1) | AU2012282772A1 (enExample) |
| BR (1) | BR112014000620A2 (enExample) |
| CA (1) | CA2841833A1 (enExample) |
| IN (1) | IN2014CN00508A (enExample) |
| MX (1) | MX2014000481A (enExample) |
| PH (1) | PH12014500099A1 (enExample) |
| RU (1) | RU2014104691A (enExample) |
| TW (1) | TW201322678A (enExample) |
| WO (1) | WO2013009777A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019531616A (ja) * | 2016-07-22 | 2019-10-31 | プロテウス デジタル ヘルス， インコーポレイテッド | 摂取可能なイベント・マーカの電磁気的感知および検出 |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3827747A1 (en) | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
| EP3173125B1 (en) | 2008-07-30 | 2019-03-27 | Ecole Polytechnique Fédérale de Lausanne | Apparatus for optimized stimulation of a neurological target |
| CA2743575C (en) | 2008-11-12 | 2017-01-31 | Ecole Polytechnique Federale De Lausanne | Microfabricated neurostimulation device |
| BR122013009559A2 (pt) | 2009-04-28 | 2019-08-06 | Proteus Digital Health, Inc. | Marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos |
| EP2506920B1 (en) | 2009-12-01 | 2016-07-13 | Ecole Polytechnique Fédérale de Lausanne | Microfabricated surface neurostimulation device and method of making the same |
| JP5927176B2 (ja) | 2010-04-01 | 2016-06-01 | エコーレ ポリテクニーク フェデラーレ デ ローザンヌ （イーピーエフエル） | 神経組織と相互作用するためのデバイス、ならびにそれを作製および使用する方法 |
| RU2012143791A (ru) | 2010-04-07 | 2014-05-20 | Проутьюс Диджитал Хэлс, Инк. | Миниатюрное проглатываемое устройство |
| JP2014504902A (ja) | 2010-11-22 | 2014-02-27 | プロテウス デジタル ヘルス， インコーポレイテッド | 医薬品を有する摂取可能なデバイス |
| WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| US20130261410A1 (en) * | 2012-03-28 | 2013-10-03 | Larger Reality Technologies LLC | System and Method for Body and In-Vivo Device, Motion and Orientation Sensing and Analysis |
| TWI659994B (zh) | 2013-01-29 | 2019-05-21 | 美商普羅托斯數位健康公司 | 高度可膨脹之聚合型薄膜及包含彼之組成物 |
| US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
| US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
| JP6354143B2 (ja) | 2013-12-10 | 2018-07-11 | Tdk株式会社 | 情報提供システム、電子機器、方法及びプログラム |
| WO2015119911A1 (en) * | 2014-02-04 | 2015-08-13 | Proteus Digital Health, Inc. | Enhanced ingestible event indicators and methods for making and using the same |
| CN110585588A (zh) | 2014-05-16 | 2019-12-20 | 阿莱瓦神经治疗股份有限公司 | 可植入式微电极装置 |
| US11311718B2 (en) | 2014-05-16 | 2022-04-26 | Aleva Neurotherapeutics Sa | Device for interacting with neurological tissue and methods of making and using the same |
| US9403011B2 (en) | 2014-08-27 | 2016-08-02 | Aleva Neurotherapeutics | Leadless neurostimulator |
| US9474894B2 (en) | 2014-08-27 | 2016-10-25 | Aleva Neurotherapeutics | Deep brain stimulation lead |
| US9925376B2 (en) | 2014-08-27 | 2018-03-27 | Aleva Neurotherapeutics | Treatment of autoimmune diseases with deep brain stimulation |
| US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
| US10517508B2 (en) * | 2016-03-10 | 2019-12-31 | Etectrx, Inc. | Ingestible bio-telemetry communication network and associated systems |
| JP2019535377A (ja) | 2016-10-26 | 2019-12-12 | プロテウス デジタル ヘルス， インコーポレイテッド | 摂取可能なイベントマーカを有するカプセルの製造方法 |
| US10610694B2 (en) * | 2017-01-20 | 2020-04-07 | Medtronic, Inc. | Implanted electrode configuration for physiological sensing and tissue conductance communication |
| US10702692B2 (en) | 2018-03-02 | 2020-07-07 | Aleva Neurotherapeutics | Neurostimulation device |
| EP4058106B1 (en) * | 2019-11-14 | 2025-06-25 | Sanofi | A drug delivery device mitigating dose measurement errors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5318557A (en) * | 1992-07-13 | 1994-06-07 | Elan Medical Technologies Limited | Medication administering device |
| US6076016A (en) * | 1995-10-19 | 2000-06-13 | Feierbach; Gary F. | Galvanic transdermal conduction communication system and method |
| DE19983480T1 (de) * | 1998-09-18 | 2001-11-29 | Hitachi Maxell | Halbleitervorrichtung zur kontaktlosen Kommunikation |
| US7368190B2 (en) * | 2002-05-02 | 2008-05-06 | Abbott Diabetes Care Inc. | Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
| US7392091B2 (en) * | 2003-12-30 | 2008-06-24 | Cochlear Limited | Implanted antenna and radio communications link |
| US7498940B2 (en) * | 2004-06-22 | 2009-03-03 | Vubiq, Inc. | RFID system utilizing parametric reradiated technology |
| EP3827747A1 (en) * | 2005-04-28 | 2021-06-02 | Otsuka Pharmaceutical Co., Ltd. | Pharma-informatics system |
| JP5916277B2 (ja) * | 2006-10-25 | 2016-05-11 | プロテウス デジタル ヘルス， インコーポレイテッド | 摂取可能な制御活性化識別子 |
| WO2008112578A1 (en) * | 2007-03-09 | 2008-09-18 | Proteus Biomedical, Inc. | In-body device having a deployable antenna |
| CA2717862C (en) * | 2008-03-05 | 2016-11-22 | Proteus Biomedical, Inc. | Multi-mode communication ingestible event markers and systems, and methods of using the same |
| AU2009281876B2 (en) * | 2008-08-13 | 2014-05-22 | Proteus Digital Health, Inc. | Ingestible circuitry |
| CA2746650A1 (en) * | 2008-12-11 | 2010-06-17 | Proteus Biomedical, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
-
2011
- 2011-07-11 US US13/180,498 patent/US20120004520A1/en not_active Abandoned
-
2012
- 2012-07-10 CA CA2841833A patent/CA2841833A1/en not_active Abandoned
- 2012-07-10 CN CN201280043438.7A patent/CN103781412A/zh active Pending
- 2012-07-10 RU RU2014104691/14A patent/RU2014104691A/ru not_active Application Discontinuation
- 2012-07-10 BR BR112014000620A patent/BR112014000620A2/pt not_active Application Discontinuation
- 2012-07-10 MX MX2014000481A patent/MX2014000481A/es not_active Application Discontinuation
- 2012-07-10 IN IN508CHN2014 patent/IN2014CN00508A/en unknown
- 2012-07-10 KR KR1020147003324A patent/KR20140126282A/ko not_active Withdrawn
- 2012-07-10 EP EP12810909.7A patent/EP2731495A4/en not_active Withdrawn
- 2012-07-10 WO PCT/US2012/046113 patent/WO2013009777A2/en not_active Ceased
- 2012-07-10 PH PH1/2014/500099A patent/PH12014500099A1/en unknown
- 2012-07-10 JP JP2014520261A patent/JP2014522694A/ja active Pending
- 2012-07-10 AU AU2012282772A patent/AU2012282772A1/en not_active Abandoned
- 2012-07-11 TW TW101124931A patent/TW201322678A/zh unknown
-
2013
- 2013-10-21 US US14/059,336 patent/US20140179221A1/en not_active Abandoned
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019531616A (ja) * | 2016-07-22 | 2019-10-31 | プロテウス デジタル ヘルス， インコーポレイテッド | 摂取可能なイベント・マーカの電磁気的感知および検出 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP2731495A4 (en) | 2015-08-05 |
| CN103781412A (zh) | 2014-05-07 |
| KR20140126282A (ko) | 2014-10-30 |
| US20120004520A1 (en) | 2012-01-05 |
| MX2014000481A (es) | 2014-09-08 |
| EP2731495A2 (en) | 2014-05-21 |
| WO2013009777A3 (en) | 2013-03-21 |
| TW201322678A (zh) | 2013-06-01 |
| CA2841833A1 (en) | 2013-01-17 |
| IN2014CN00508A (enExample) | 2015-04-03 |
| WO2013009777A2 (en) | 2013-01-17 |
| AU2012282772A1 (en) | 2014-01-30 |
| RU2014104691A (ru) | 2015-08-20 |
| BR112014000620A2 (pt) | 2017-02-14 |
| US20140179221A1 (en) | 2014-06-26 |
| PH12014500099A1 (en) | 2014-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6259395B2 (ja) | 複数の通信装置を製造する方法 | |
| JP5805315B2 (ja) | 摂取可能な製品に組み込まれた通信システム | |
| JP2014522694A (ja) | 複数の電源を備えた通信システム | |
| AU2017202754B2 (en) | Communication system with remote activation | |
| JP2014526918A (ja) | 埋め込み型装置を用いた通信システム | |
| HK1196239B (en) | Communication system with remote activation | |
| HK1196931A (en) | Communication system with multiple sources of power | |
| HK1196240B (en) | Communication system incorporated in an ingestible product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140516 |